Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gut microbiota metabolites present in pregnant and breastfeeding period Women

ABSTRACT: Human gut microbiota metabolites associated with pregnancy and lactation stages.

INSTRUMENT(S): 6510 Quadrupole Time-of-Flight LC/MS

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: sara londono

PROVIDER: MSV000088880 | MassIVE | Mon Feb 21 11:51:00 GMT 2022

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Gut microbiota metabolites present in pregnant and breastfeeding period Women

Project description:Human gut microbiota metabolites associated with pregnancy and lactation stages.

2022-03-30 | MSV000089161 | MassIVE

GNPS - Gut microbiota metabolites present in pregnant and breastfeeding period Women

Project description:Human gut microbiota metabolites associated with pregnancy and lactation stages.

2022-03-30 | MSV000089161 | GNPS

GNPS - Gut microbiota metabolites present in pregnant and breastfeeding period Women

Project description:Human gut microbiota metabolites associated with pregnancy and lactation stages.

2022-02-21 | MSV000088880 | GNPS

Chronic alcohol-induced dysbiosis of the gut microbiota and gut metabolites impairs sperm quality

Project description:Purpose: To explore whether chronic alcohol consumption affects sperm quality by inducing changes in the gut microbiota.

2022-12-21 | GSE192522 | GEO

Vaginal microbiota, pregnant women

Project description:Parity and gestational age associates with vaginal microbiota composition in term and late term pregnancies

| PRJEB47492 | ENA

vaginal microbiota of pregnant women

Project description:vaginal microbiota of pregnant women

| PRJEB10913 | ENA

Impacts on the Placenta-Brain Axis in Pregnant Mice Devoid of Gut Microbiota

Project description:Gut microbiota play an important role in regulating individual health. It is also increasingly apparent that changes in maternal gut microbiota result can render her offspring more susceptible to diseases later in life. Such bacterial induced changes likely originate in the womb. As the placenta is the primary communication organ between mother and conceptus, it is vulnerable to in utero environmental changes, including those associated with maternal gut microbiota. The placenta also relays nutritional and other factors, including serotonin, to the developing fetal brain that help guide development of this organ. Thus, placental disruptions can influence the placenta-brain axis and subsequently neurobehavioral programming with potential long-term consequences. One mechanism by which changes in maternal gut microbiota might effect the placenta are through alterations in bacterial short chained fatty acids (SCFA). The hypothesis, thus, tested in the current studies is that absence of a maternal gut microbiota, as occurs in germ-free (GF) mice, would impact bacterial SCFA in her fecal samples and in the fetal placenta and brain. Secondarily, we tested whether transcriptomic changes would be evident in the placenta and fetal brain from conceptuses derived from GF relative to multi-pathogen free (MPF) pregnant females.

2025-12-22 | GSE314569 | GEO

human gut metagenome

Project description:Maternal gut microbiota during pregnancy and lactation

| PRJNA187552 | ENA

Cerebrospinal fluid of preeclamptic and normotensive pregnant women compared to non-pregnant women analyzed with mass spectrometry.

Project description:The objective of the present study was to study whether pregnancy-related proteins are associated with preeclampsia.

2021-09-09 | PXD017862 | Pride

Gut microbiota promote immune tolerance at the maternal-fetal interface

Project description:Immune tolerance at the maternal-fetal interface is required for fetal development. Excessive maternal interferon gamma (IFNγ) and interleukin-17 (IL-17) is linked to pregnancy complications, but the regulation of maternal IFNγ and IL-17 at the maternal-fetal interface (MFI) is poorly understood. Here we demonstrate a gut-placenta immune axis in pregnant mice in which the absence or perturbation of gut microbiota dysregulates maternal IFNγ and IL-17 responses at the MFI, resulting in fetal resorption. Microbiota-dependent tryptophan derivatives suppress IFNγ+ and IL-17+ T cells at the MFI by priming myeloid-derived suppressor cells (MDSCs) and gut-derived RORγt+ Tregs, respectively. The tryptophan derivative indole-3-carbinol, or tryptophan-metabolizing Lactobacillus murinus, rebalances the T cell response at the MFI and reduces fetal resorption in germ-free mice. Furthermore, MDSCs, RORγt+ Tregs, and microbiota-dependent tryptophan derivatives are dysregulated at the MFI in human recurrent miscarriage cases. Together, our findings identify microbiota-dependent immune tolerance mechanisms that promote fetal development.

2025-12-17 | GSE310031 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data